Enspectra receives breakthrough status for AI-powered skin imaging platform
/
DateJun 06 2024
The AI-powered VIO Skin Platform can evaluate lesions indicative of basal cell and squamous cell carcinomas. Enspectra Health has secured breakthrough device designation (BDD) from... Read More →


















